Also trades as: BIOV.CN (CNQ) · $vol 0M
BVAXF OTC
BioVaxys Technology Corp.
1W: -5.5%
1M: +21.9%
3M: -43.3%
YTD: -50.4%
1Y: -61.2%
3Y: -42.8%
5Y: -97.5%
$0.09
+0.00 (+0.95%)
Weekly Expected Move ±49.2%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$3M
-29.9% ▼
Net Income
-$4M
+48.6% ▲
EPS (Diluted)
$-0.20
+64.7% ▲
EBITDA
$0
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $239K | $726K | $963K | $134K | $2K |
| SG&A Expenses | $763K | $5M | $3M | $2M | $3M |
| Operating Expenses | $1M | $6M | $4M | $2M | $3M |
| Operating Income | -$1M | -$6M | -$4M | -$2M | -$3M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$1M | -$6M | -$12M | -$8M | -$4M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$6M | -$12M | -$8M | -$4M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.39 | $-0.78 | $-1.20 | $-0.57 | $-0.20 |
| EBITDA | -$1M | -$6M | $0 | $0 | $0 |
| Shares Outstanding | 3M | 8M | 10M | 13M | 20M |